STIM: neurostar.com Growth-Adjusted Market Cap to Net Income

Symbol and logo of brand neurostar.com (STIM)

Neuronetics, Inc. (STIM) develops specialized systems for treating depression. The PEG ratio allows for a valuation of Neuronetics, Inc. (STIM), where 0.00 represents the latest metric reading. Revenues rely on physician recognition of magnetic stimulation efficacy and insurance coverage. Device assembly is handled internally, with electronics sourced from external partners. The mature NeuroStar product line serves as a modern non-invasive solution.

Neuronetics, Inc. (STIM) - PEG Multiple from 07/04/2022 to 11/10/2026

Neuronetics, Inc. (STIM) - metric breakdowns and financial figures

- current price and projected stock value:
Price Chart Neuronetics Inc.|STIM - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization NeuroStar|STIM - Real Price to Acquire Entire Company
- company book value details:
Share Book Value Neuronetics|STIM - Book Capitalization|Market-to-Book Ratio neurostar.com|STIM - Company Total Assets
- business debt structure and liquidity details:
Debt to Equity Ratio Neuronetics, Inc.|STIM - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital neurostar.com|STIM - Company Debts|Debt to Book Value NeuroStar|STIM - Company Long-Term Debts|Short-Term Debt Neuronetics|Immediate Liquidity Ratio neurostar.com
- earnings and valuation multiples indicators:
STIM - Net Profit|Company Profit Forecast Neuronetics, Inc.|STIM - P/E Multiple|Projected Price to Earnings Neuronetics, Inc|STIM - PEG Multiple|EV/EBITDA Multiple NeuroStar|STIM - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Neuronetics|STIM - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months neurostar.com|STIM - Earnings growth in current year|Expected net earnings per share growth next year Neuronetics, Inc.
Fundamental company analysis:STIM (Neuronetics Inc.)
Manufactured products of neurostar.com

As a manufacturer of neurostimulation systems, Neuronetics, Inc. (STIM) faces risks associated with slow market adoption of its technologies and competition from pharmacological treatments. The PEG ratio compares market valuation with earnings growth, identifying an undervalued asset when the value falls below one. Analyzing this chart helps determine whether the business's expansion potential offsets current challenges regarding insurance reimbursement.

Competing companies

Price/Earnings to Growth Ratio BSX (Boston Scientific Corp)|PEG Multiple EW (Edwards Lifesciences Corp)|Growth-Adjusted Market Cap to Net Income ResMed Corporation (RMD)|PODD: Price/Earnings to Growth Multiple|Market Cap to Earnings and Growth Ratio ZBH|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Invisalign (ALGN)|GMED (Globus Medical Corp) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (transmedics.com)|Price/Earnings to Growth Multiple ATEC (Alphatec Holdings, Inc.)|AORT (artivion.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enovis ENOV|IART - Price/Earnings to Growth Multiple|Motiva - PEG Multiple|Price to Earnings Adjusted for Growth Rate iLet Bionic Pancreas|IRMD: PEG Multiple|Growth-Adjusted P/E Ratio EMBC|TNDM (Tandem Diabetes Care, Inc.) - PEG Multiple|AxoGen Inc (AXGN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple SIBN|Price/Earnings to Growth Multiple Orthofix Corp OFIX|PEG Multiple BVS (Bioventus Inc.)|PEG Multiple OrthoPediatrics Corp KIDS|TMCI - Price/Earnings to Growth Ratio|SRTA: Price/Earnings to Growth Ratio|CARL (Carlsmed Corp) - Price/Earnings to Growth Multiple|RxSight Ophthalmic - Growth-Adjusted Payback Ratio|CLPT (ClearPoint Neuro Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate stereotaxis.com STXS|Price/Earnings to Growth Ratio Sight Sciences (SGHT)|Orchestra BioMed Inc. (OBIO) - Price to Net Income Growth Ratio|Anika Therapeutics, Inc. - Price/Earnings to Growth Multiple|PEG Multiple InspireMD Inc. NSPR|Jin Medical International Ltd - PEG Multiple|Growth-Adjusted Market Cap to Net Income Vivani Medical, Inc. VANI|xtantmedical.com (XTNT) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMTC (NeuroOne)|Price/Earnings to Growth Ratio Modular Medical Inc|Price/Earnings to Growth Multiple Myomo Inc (MYO)|PEG Multiple COCH|VVOS - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio enVVeno Medical Corp. NVNO|SINT: Growth-Adjusted P/E Ratio|TNON: Price/Earnings to Growth Multiple|Lifeward Ltd. - Company Value to Earnings Growth Ratio|autonomix.com (AMIX) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio IVF|BBLG (Bone Biologics Corp) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Axonics Inc. AXNX|Price/Earnings to Growth Multiple BIOL (Biolase, Inc.)|PEG Multiple dynatronics.com (DYNT)|Price/Earnings to Growth Ratio Paragon 28 FNA|Growth-Adjusted Payback Ratio INVO